Eli Lilly takes weight-loss pill battle global with first Foundayo approval outside U.S.

CNBC reports that Eli Lilly's weight-loss pill Foundayo has received approval in the United Kingdom, marking its first authorization outside the United States. The drug now enters global competition with other weight-loss medications, including Novo Nordisk's Wegovy.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton